Regentis Biomaterials (NYSE American: RGNT) to Present at 2026 ThinkEquity Conference on Oct. 15
Alpha Vantage · Benzinga · · AI-summarised by FinFlash
Regentis Biomaterials (NYSE American: RGNT) announced that its CEO and Executive Chairman, Ehud Geller, will present at the 2026 ThinkEquity Conference on October 15, 2026. Geller will discuss the company's GelrinC(R) technology, recent clinical developments, and progress in its U.S. FDA pivotal Phase III trial, as well as European commercialization plans.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.